期刊文献+

盐酸吡格列酮对糖尿病大鼠尿nephrin排泄的影响 被引量:6

Effect of different dosages of pioglitazone on the excretion of urinary nephrin in STZ-induced diabetic rats
下载PDF
导出
摘要 目的观察不同剂量盐酸吡格列酮(PIO)对糖尿病大鼠尿nephrin(UNE)排泄的动态影响,探讨噻唑烷二酮类药物(TZDs)对肾小球足细胞的保护作用。方法 32只链脲佐菌素(STZ)诱导的糖尿病大鼠随机分为4组:模型组(DM组)和不同剂量PIO干预组[DR1、DR2、DR3组,分别给予PIO:10、20、30 mg/(kg.d)],设正常对照组(NC组)。干预前后动态监测血糖(BG)、糖化血红蛋白(HbA1c)、尿白蛋白(UACR)、UNE、尿肌酐(Ucr)。结果①4组糖尿病大鼠BG及HbA1c均明显高于NC组(P<0.01),而4组之间差异无显著性。②4周末,DR2和DR3组UACR较DM组显著降低(P<0.01),而DR1组与DM组间差异无显著性;8周末,各干预组UACR均较模型组明显降低(P<0.01),DR2组和DR3组UACR较DR1组降低明显(P<0.05)。③0周5组大鼠尿中均检测到nephrin,但差异无显著性;4周末DM组UNE排泄显著高于各干预组(P<0.05),但各干预组间差异无显著性;8周末各干预组UNE较DM组均显著降低(P<0.05),DR2和DR3组UNE与DR1组相比均显著降低(P<0.05),而DR2与DR3组间UNE差异无显著性。④Pearson相关分析显示UNE与UACR存在正相关(r=0.881,P<0.01)。结论 PIO可降低糖尿病大鼠UNE的排泄,且具有一定的剂量依赖性。 Objective To observe the effect of different dosages of hydrochloride pioglitazone(PIO) on the excretion of urinary sediment nephrin(UNE) in STZ-induced diabetic rats,and to investigate the protective effects of thiazolidinediones(TZDs) on podocyte.Methods 32 STZ-induced diabetic rats were randomly divided into following four groups: model diabetic rats(DM group),10,20 and 30 mg/(kg·d)PIO-treated diabetic rats(DR1,DR2 and DR3 group,respectively,n=8),in addition,8 healthy rats were served as normal control group(NC group).The peripheral blood glucose(BG),glycated haemoglobin(HbA1c),urinary albumin(UACR),UNE and urinary creatinine were measured in the experimental period.Results ① The BG and HbA1c levels in all diabetic rats were significantly increased(P0.01,versus group NC),but no significant differences among diabetic rats.② At the 4th week,UACR was significantly decreased in DR2 and DR3 group(P0.01,versus group DM),which in DR1 group decreased slightly;At the 8th week,UACR in PIO-treated group was significantly lower than that of DM group,which in DR2 and DR3 group were significantly lower than that of DR1 group.③ At the first day,UNE could be detected in five groups,but no significant differences;At the 4th week,UNE was significantly reduced in PIO-treated groups(P0.05,versus DM group),but no differences among the PIO-treated groups;At the 8th week,UNE was significantly reduced in PIO-treated groups(P0.05,versus DM group).UNE was significantly decreased in DR2 and DR3 group(P0.05,versus DR1 group),but no difference between DR2 and DR3 group.④ Pearson correlation analysis showed that UNE was positively correlated with UACR(r=0.881,P0.01).Conclusion PIO can restrain UNE with a dose-dependent mode.
出处 《安徽医科大学学报》 CAS 北大核心 2011年第10期1029-1031,共3页 Acta Universitatis Medicinalis Anhui
基金 安徽省自然基金项目(项目编号:070413255X) 安徽省人事厅高级人才资助项目(项目编号:2008Z048)
关键词 糖尿病肾病 足细胞 蛋白尿 噻唑烷二酮类 diabetic nephropathy podocytes proteinuria thiazolidinediones
  • 相关文献

参考文献9

  • 1Sarafidis P A, Stafylas P C, Georgianos P I, et al. Effect of thiazo- lidinediones on albuminuria and proteinuria in diabetes: a meta-a- nalysis[ J]. Am J Kidney Dis,2010,55 (5) :835 - 47.
  • 2Kanno K, Kawachi H, Uchida Y, et al. Urinary sediment podocalyx- in in children with glomerular diseases [ J ]. Nephron Clin Pract, 2003,95(3) :C91 -9.
  • 3Aaltonen P, Luimula P, Astrom E, et al. Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy [ J ]. Lab Invest,2001,81 (9) : 1185 - 90.
  • 4陈立平,周巧玲,欧阳春,彭卫生,刘抗寒,吴晓英,尹红玲.罗格列酮对糖尿病肾病大鼠足细胞nephrin和podocin表达的影响[J].中华肾脏病杂志,2007,23(4):263-264. 被引量:16
  • 5Kanjanabuch T, Ma L J, Chen J, et al. PPAR-gamma agonist pro- tects podocytes from injury[ J]. Kidney Int,2007,71 (12) :1232 - 9.
  • 6Durvasula R V, Shankland S J. Activation of a local renin angio- tensin system in podocytes by glucose [ J ]. Am J Physiol Renal Physiol,2008,294 (4) : 830 - 9.
  • 7Sugawara A, Uruno A, Kudo M,et al. Effects of PPARγ on hyper- tension, atherosclerosis, and chronic kidney disease [ J ]. Endocr J,2010,57(10) : 847 -52.
  • 8Ohga S, Shikata K, Yozai K, et al. Thiazolidinedione ameliorates re- nal injury in experimental diabetic rats through antiinflammatory effects mediated by inhibition of NF-kappaB activation [ J ]. Am J Physiol Renal Rhysid ,2007,292 (4) : 1141 - 50.
  • 9周晓惠,王佑民,王文平,王丽萍,吕齐欢.吡格列酮和非诺贝特对高脂饲养大鼠脂联素与胰岛素抵抗的影响[J].安徽医科大学学报,2008,43(4):418-421. 被引量:3

二级参考文献14

  • 1胡红琳,王佑民,王长江,周剑,代芳,佘其美,时照明.2型糖尿病患者血清脂联素水平的变化[J].安徽医科大学学报,2005,40(3):249-251. 被引量:2
  • 2Saleem MA, O'Hare MJ, Reiser J, et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol, 2002, 13:630-638.
  • 3Koop K, Eikmans M, Baelde HJ, et al. Expression of podocyte-assoociated molecules in acquired human kidney diseases. J Am Soc Nephrol, 2003, 14:2063-2071.
  • 4Guan YF, Breyer MD. Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. Kidney Int, 2001, 60:14-30.
  • 5Pistrosch F, Herbrig K, Kindel B, et al. Rosiglitazone improves glomerular hyperfihration,renal endothelial dysfunction,and mieroalbuminuria of incipient diabetic nephropathy in patients. Diabetes, 2005, 54:2206-2211.
  • 6Isshiki K, Haneda M, Koya D, et al. Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes,2000, 49:1022-1032.
  • 7Okamoto Y, Kihara S, Funahashi T, et al. Adiponectin : a key Adipocytokine in metabolic syndrome [ J ]. Clin Sci ( Lond ) ,2006,110 (3) :267 -78.
  • 8Lee M Y,Lee E Y,Lee B J,et al. Beneficial effects of thiazolidine- diones on diabetic nephropathy in OLETF rats[J]. Yonsei Med J, 2007,48(2) :301 -7.
  • 9Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase [ J ]. Nat Med,2002,8 ( 11 ) : 1288 - 95.
  • 10Kubota N,Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation [ J ]. J Biol Chem,2002,277(29) :25863 -6.

共引文献17

同被引文献57

  • 1叶山东,荆春艳,范艾红,陈燕.福辛普利和氯沙坦对糖尿病伴白蛋白尿患者尿转化生长因子-β_1排泄的影响[J].中国临床保健杂志,2005,8(1):6-8. 被引量:2
  • 2董向让,金仲品.Nephrin与糖尿病肾病[J].生命的化学,2006,26(5):448-451. 被引量:2
  • 3陈立平,周巧玲,彭卫生,吴晓英.足细胞超微结构及其相关分子表达变化在糖尿病肾病发病中的作用[J].中南大学学报(医学版),2007,32(4):620-625. 被引量:21
  • 4Tryggvason K. Unraveling the machanisms glomerular uhrafiltra- tion : nephrin, a key compinent of the slitdiaphragm [ J ]. J Am Soc Nephrol, 1999, 10 ( 11 ) : 2440 - 5.
  • 5Doublier S, Salvidio G, Lupia E, et al. Nephrin expression is re- duced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II [ J ]. Diabetes, 2003, 52 (4) : 1023 -30.
  • 6Keane W F, Brenner B M, de Zeeuw D, et al. The risk of develo- ping end-stagerenal disease in patients with type 2 diabetes and nephr opathy : the RENAAL study [ J ]. Kidney Int,2003,63 (4) : 1499 - 507.
  • 7Langham R G, Kelly D J, Cox A J, et al. Proteinuria and the ex- pression othepodocyte slitdiaphragm protein, nephrin, in diabetic nephropathy: effectsof angiotensin converting enzyme inhibition [ J ]. Diabetologia, 2002,4 ( 11 ) : 1572 - 6.
  • 8Doublier S,Ruotsalainen V, Salvidio G, et al. Nephrin redistribu- tion onpodocytes is a potential mechanismfor proteinuria in pa- tientswith primary acquired nephritic syndrome[ J]. Am J Pathol, 2001, 158(5): 1723-31.
  • 9Okada T, Wada J, Hida K, et al. Thiazolidinediones ameliorate dabetic nephropathy via cell cycle-dependent mechanisms [ J ]. Diabetes,2006,55 (6) : 1666-1677.
  • 10Ohga S, Shikata K, Yozai K, et al. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory efects mediated by inhibition of NF- { kappa t B activation [ J ]. Am J Physiol Renal,2007,292 (4) : F1141 -F1150.

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部